High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old. Botty van den Bruele A, Ren Y, Thomas SM, Ntowe KW, et al. Breast Cancer Res Treat 2025;211:421-429.

Read + Share

Amedeo Smart

Independent Medical Education

Botty van den Bruele A, Ren Y, Thomas SM, Ntowe KW, et al. High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old. Breast Cancer Res Treat 2025;211:421-429.
PMID: 40016543